LDS/Medical Tests/T-Cell Antigen Receptor, Gamma (TRG@) Gene Rearrangement Analysis for Abnormal Clonality, Amplified Method, Tissue

T-Cell Antigen Receptor, Gamma (TRG@) Gene Rearrangement Analysis for Abnormal Clonality, Amplified Method, Tissue

The evaluation of lymph nodes, bone marrows, and other tissues for the presence of lymphoma usually involves a multiparameter approach. The obligatory first step when evaluating a tissue for suspected lymphoma is to examine the tissue microscopically for morphology. In many cases, morphologic examination is sufficient to establish a diagnosis of malignant lymphoma. However, in a significant proportion of cases, additional studies are needed in order to establish a definitive diagnosis. Those additional studies include immunoperoxidase staining of the tissue sections, flow cytometric evaluation of fresh cells from the specimen, and molecular analysis. Molecular analysis includes such modalities as cytogenetics (including FISH) and polymerase chain reaction (PCR). All of these special studies are intended to provide some evidence that can help to distinguish between benign lymphadenopathy and malignant lymphoma. In addition, the special tests can sometimes help to establish both the lineage and the presence of prognostically significant subtypes of malignant lymphoma.

In general, the percentage of T lymphocytes with identical T-cell receptors is very low; in malignancies, however, the clonal expansion of one population leads to a large number of cells with identical T-cell receptor gene rearrangement.  Under normal circumstances, T-cell genes (alpha, beta, delta and gamma) somatically rearrange to produce cell surface receptors that are either alpha/beta dimers (90-95% of normal T cells) or delta/gamma dimers (5-10% of normal T cells).  The marked diversity of this process is important for normal immune system function; however, in neoplastic  T-cell disorders there may be a predominance of one particular rearrangement pattern (monoclonality) and this serves as a marker for a neoplastic process, with few exceptions.  Monoclonal patterns can be detected by molecular techniques such as PCR.

  • Identification of clonal T cell population(s) in tissue suspected of harboring a neoplastic lymphoproliferative lesion in order to determine if the process is polyclonal (benign) versus monoclonal (malignant).
  • As an aid in diagnosis of T-cell malignancies
  • To determine leukemia and lymphoma lineage
  • To monitor for minimal residual disease or recurrent disease

Positive: Clonal T-cell receptor gene rearrangement was detected. Detection of a clonal T-cell receptor gene rearrangement does not necessarily indicate the presence of a T-cell neoplasm. Apparent clonal T-cell populations are particularly likely to occur in settings where there is physiologic restriction of the T-cell repertoire, such as occurs in autoimmune disorders or with normal aging. Therefore, correlation with pathologic, clinical and other supporting (e.g. immunophenotypic) findings is required for final interpretation of these results.

Negative: No clonal T-cell receptor gene rearrangement was detected. Absence of a clonal T-cell receptor gene rearrangement does not necessarily exclude the possibility of a T-cell neoplasm and correlation with pathologic, clinical and other supporting (e.g. immunophenotypic) findings is required for final interpretation of these results.

Results usually reported as: Positive, negative, or indeterminate for a clonal T-cell population

Negative for gene rearrangement
 

 

Flow Cytometry (immunophenotyping), Restriction fragment length polymorphism, polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH)

Whole blood collected in anti coagulant tubes (EDTE) such as purple or lavender top tube, bone marrow, or paraffin-embedded tissue.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
Disease specific gene translocation by RT-PCT, bone marrow morphology, lymphoma, and leukemia antibody profile (phenotyping) using flow cytometry (blood and bone marrow), detection of specific and known chromosomal translocations by FISH or RT-PCR, chromosomal abnormalities by cytogenetic testing and, detection of minimal residual disease by PCR.
5- 8 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login